Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gastric Cancer

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    June 2021
  1. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  2. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    PubMed     Abstract available


    March 2021
  3. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    PubMed    


  4. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    PubMed    


    January 2021
  5. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    PubMed    


  6. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    PubMed    


    November 2020
  7. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    PubMed    


    October 2020
  8. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    PubMed     Abstract available


  9. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    PubMed     Abstract available


  10. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    PubMed     Abstract available


    September 2020
  11. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    PubMed     Abstract available


  12. KAMARAJAH SK, Phillips AW
    Author response: Anastomotic leak does impact on long-term survival in gastric cancer patients.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11944.
    PubMed    


  13. KAMARAJAH SK, Phillips AW
    Author response to: Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11953.
    PubMed    


  14. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11954.
    PubMed    


    August 2020
  15. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    PubMed     Abstract available


    June 2020
  16. KAMARAJAH SK, Navidi M, Griffin SM, Phillips AW, et al
    Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Jun 13. doi: 10.1002/bjs.11749.
    PubMed     Abstract available


  17. AN JY, Min JS, Hur H, Lee YJ, et al
    Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA).
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11655.
    PubMed     Abstract available


    May 2020
  18. RI M, Nunobe S, Honda M, Akimoto E, et al
    Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicentre cohort study.
    Br J Surg. 2020 May 20. doi: 10.1002/bjs.11702.
    PubMed     Abstract available


    February 2020
  19. ROH CK, Choi S, Seo WJ, Cho M, et al
    Indocyanine green fluorescence lymphography during gastrectomy after initial endoscopic submucosal dissection for early gastric cancer.
    Br J Surg. 2020 Feb 7. doi: 10.1002/bjs.11438.
    PubMed     Abstract available


  20. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    PubMed     Abstract available


    January 2020

  21. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2020;107:120.
    PubMed    


  22. SAUNDERS JH, Yanni F, Dorrington MS, Bowman CR, et al
    Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
    Br J Surg. 2020;107:103-112.
    PubMed     Abstract available


    November 2019
  23. DATTA J, Da Silva EM, Kandoth C, Song T, et al
    Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
    Br J Surg. 2019 Nov 25. doi: 10.1002/bjs.11443.
    PubMed     Abstract available


    October 2019
  24. MISAWA K, Mochizuki Y, Sakai M, Teramoto H, et al
    Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303.
    PubMed     Abstract available


    September 2019
  25. ZHAO Z, Wang Y
    Comment on: Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Br J Surg. 2019;106:1416.
    PubMed    


    August 2019
  26. ALLUM WH, Smyth EC, Blazeby JM, Grabsch HI, et al
    Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction.
    Br J Surg. 2019;106:1204-1215.
    PubMed     Abstract available


  27. LIN JX, Yoon C, Desiderio J, Yi BC, et al
    Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Br J Surg. 2019;106:1187-1196.
    PubMed     Abstract available


    July 2019
  28. BROZA YY, Khatib S, Gharra A, Krilaviciute A, et al
    Screening for gastric cancer using exhaled breath samples.
    Br J Surg. 2019 Jul 1. doi: 10.1002/bjs.11294.
    PubMed     Abstract available


    June 2019
  29. CHEN AH, Chan WH, Lee YH, Tseng JH, et al
    Routine chest CT for staging of gastric cancer.
    Br J Surg. 2019 Jun 18. doi: 10.1002/bjs.11186.
    PubMed     Abstract available



  30. Snapshot quiz.
    Br J Surg. 2019;106:878.
    PubMed    


    August 2018
  31. VAN PUTTEN M, Nelen SD, Lemmens VEPP, Stoot JHMB, et al
    Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    Br J Surg. 2018 Aug 22. doi: 10.1002/bjs.10931.
    PubMed     Abstract available


    June 2018
  32. NAVIDI M, Phillips AW, Griffin SM, Duffield KE, et al
    Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
    Br J Surg. 2018;105:900-906.
    PubMed     Abstract available


    May 2018
  33. KANDA M, Shimizu D, Tanaka H, Tanaka C, et al
    Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Br J Surg. 2018 May 9. doi: 10.1002/bjs.10876.
    PubMed     Abstract available


  34. CLAASSEN YHM, van Sandick JW, Hartgrink HH, Dikken JL, et al
    Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
    Br J Surg. 2018;105:728-735.
    PubMed     Abstract available


    April 2018
  35. ZENG D, Zhou R, Yu Y, Luo Y, et al
    Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Br J Surg. 2018 Apr 25. doi: 10.1002/bjs.10871.
    PubMed     Abstract available


  36. NELEN SD, Bosscha K, Lemmens VEPP, Hartgrink HH, et al
    Morbidity and mortality according to age following gastrectomy for gastric cancer.
    Br J Surg. 2018 Apr 23. doi: 10.1002/bjs.10836.
    PubMed     Abstract available


  37. VAN DER KAAIJ RT, de Rooij MV, van Coevorden F, Voncken FEM, et al
    Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
    Br J Surg. 2018;105:561-569.
    PubMed     Abstract available


    January 2018
  38. MARKAR SR, Mackenzie H, Wiggins T, Askari A, et al
    Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Br J Surg. 2018;105:113-120.
    PubMed     Abstract available


  39. POWELL AGMT, Soul S, Christian A, Lewis WG, et al
    Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.
    Br J Surg. 2018;105:e61-e68.
    PubMed     Abstract available


  40. VAN DER KAAIJ RT, van Kessel JP, van Dieren JM, Snaebjornsson P, et al
    Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2018;105:e176-e182.
    PubMed     Abstract available


    December 2017
  41. NOBLE F, Lloyd MA, Turkington R, Griffiths E, et al
    Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
    Br J Surg. 2017;104:1816-1828.
    PubMed     Abstract available


  42. KAWAKATSU S, Ohashi M, Hiki N, Nunobe S, et al
    Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer.
    Br J Surg. 2017;104:1829-1836.
    PubMed     Abstract available


    November 2017
  43. POLOM K, Marano L, Marrelli D, De Luca R, et al
    Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
    Br J Surg. 2017 Nov 1. doi: 10.1002/bjs.10663.
    PubMed     Abstract available


    October 2017
  44. DENG J, Guo J, Ma G, Zhang H, et al
    Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.
    Br J Surg. 2017 Oct 17. doi: 10.1002/bjs.10628.
    PubMed     Abstract available


    September 2017
  45. KJAER DW, Larsson H, Svendsen LB, Jensen LS, et al
    Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013.
    Br J Surg. 2017;104:1338-1345.
    PubMed     Abstract available


    August 2017
  46. NELEN SD, van Putten M, Lemmens VEPP, Bosscha K, et al
    Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10621.
    PubMed     Abstract available


  47. WANG ZX, Li GX, Zhou ZW, Huang ZP, et al
    Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.
    Br J Surg. 2017;104:1226-1234.
    PubMed     Abstract available


    May 2017
  48. LIN C, Liu H, Zhang H, Cao Y, et al
    Tryptase expression as a prognostic marker in patients with resected gastric cancer.
    Br J Surg. 2017 May 24. doi: 10.1002/bjs.10546.
    PubMed     Abstract available


  49. BENCIVENGA M, Verlato G, Han DS, Marrelli D, et al
    Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
    Br J Surg. 2017 May 10. doi: 10.1002/bjs.10551.
    PubMed     Abstract available


  50. BUSWEILER LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, et al
    Textbook outcome as a composite measure in oesophagogastric cancer surgery.
    Br J Surg. 2017;104:742-750.
    PubMed     Abstract available


    February 2017
  51. CHANG JS, Kim KH, Yoon HI, Hyung WJ, et al
    Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
    Br J Surg. 2017 Feb 28. doi: 10.1002/bjs.10502.
    PubMed     Abstract available


  52. TOKUNAGA M, Ito S, Yoshikawa T, Nunobe S, et al
    Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
    Br J Surg. 2017 Feb 27. doi: 10.1002/bjs.10509.
    PubMed     Abstract available


    January 2017
  53. IDA S, Hiki N, Cho H, Sakamaki K, et al
    Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer.
    Br J Surg. 2017 Jan 10. doi: 10.1002/bjs.10417.
    PubMed     Abstract available


  54. TAKAGANE A, Mohri Y, Konishi T, Fukushima R, et al
    Randomized clinical trial of 24 versus 72 h antimicrobial prophylaxis in patients undergoing open total gastrectomy for gastric cancer.
    Br J Surg. 2017;104:e158-e164.
    PubMed     Abstract available


    December 2016
  55. YANG HK
    Gastric cancer from operating theatre to bench in Korea.
    Br J Surg. 2016;103:e193.
    PubMed    


  56. BUSWEILER LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, et al
    Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.
    Br J Surg. 2016;103:1855-1863.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: